Literature DB >> 19383566

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

Richard A Heipertz1, Jason L Starkey, Thomas G Miller, Jianming Hu, Harriet C Isom.   

Abstract

The function of the hepatitis B virus (HBV) wild-type (WT) polymerase (pol) expressed alone or in the context of the intact genome when interacting with HBV rtM204I in HepG2 cells was compared. We show that WT pol expression from a packaging-defective RNA can complement defective rtM204I pol activity resulting in increased levels of HBV replicative intermediates (RI). Analysis of the genetically marked genomes showed that this restoration resulted from trans-complementation, rather than recombination. In contrast, we demonstrate that enhanced levels of total HBV RI observed when cells were cotransduced with both WT and rtM204I baculoviruses were predominantly WT RI. In this case, WT pol was produced from a full-length pregenomic RNA (pgRNA). We conclude that the WT pol has the capacity to trans-complement the replication defect of rtM204I; however, when expressed from an authentic pgRNA, as in a mixed infection, pol may not trans-complement efficiently.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383566      PMCID: PMC3670753          DOI: 10.1016/j.virol.2009.03.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses.

Authors:  G H Wang; F Zoulim; E H Leber; J Kitson; C Seeger
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

2.  Homologous and heterologous complementation of HBV and WHV capsid and polymerase functions in RNA encapsidation.

Authors:  R Ziermann; D Ganem
Journal:  Virology       Date:  1996-05-15       Impact factor: 3.616

3.  Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.

Authors:  M Melegari; P P Scaglioni; J R Wands
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

4.  Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.

Authors:  P Honkoop; H G Niesters; R A de Man; A D Osterhaus; S W Schalm
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

5.  Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase.

Authors:  R E Lanford; L Notvall; H Lee; B Beames
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.

Authors:  M M Bartholomew; R W Jansen; L J Jeffers; K R Reddy; L C Johnson; H Bunzendahl; L D Condreay; A G Tzakis; E R Schiff; N A Brown
Journal:  Lancet       Date:  1997-01-04       Impact factor: 79.321

7.  Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template.

Authors:  J E Tavis; D Ganem
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation.

Authors:  J R Pollack; D Ganem
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  The encapsidation signal on the hepatitis B virus RNA pregenome forms a stem-loop structure that is critical for its function.

Authors:  T Knaus; M Nassal
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

10.  Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.

Authors:  J R Pollack; D Ganem
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.